aTYR PHARMA INC (ATYR) Shareholders’ equity 2019–2025
aTYR PHARMA INC (ATYR) shareholders’ equity at each fiscal year-end, per SEC filings.
$67.5MFY2025 · since FY2019: $21.2M → $67.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $67.5M | -3.6% |
| FY2024 | $70.0M | -22.8% |
| FY2023 | $90.7M | +26.9% |
| FY2022 | $71.5M | -34.6% |
| FY2021 | $109.3M | +245.3% |
| FY2020 | $31.6M | +49.4% |
| FY2019 | $21.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice